Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban. - Zakowiecki, Daniel; Edinger, Peter; Papaioannou, Markos; Wagner, Michael; Hess, Tobias; Paszkowska, Jadwiga; Staniszewska, Marcela; Myslitska, Daria; Smolenski, Michal; Dobosz, Justyna; Garbacz, Grzegorz; Haznar Garbacz, Dorota (Pharmaceutics, 2024)